Pan American Health Organization. Area of Health Technology and Services Delivery. Unit of Essential Medicines, Vaccines and Health Technologies. Methodological guidelines for socio-cultural studies on issues related to blood donation. Washington, D.C: PAHO,  2005.

 

 

 

Technical Documents. Access to Quality Products (THS/EV-2005/004-I)

 

ISBN 92 75 12567 8

Requirements for Medicines Registration in the Americas. Washington, DC : PAHO, 2013.

(Pan American Network on Drug Regulatory Harmonization - PANDRH, Technical Document n.10).

1. Pharmaceutical Services - legislation & jurisprudence.  2. Pharmacy Administration.
3. Legislation, Pharmacy. 4. Research Report.  5. Americas. I. Title.

ISBN 978-92-75-11757-6                                                                              

Ethical Criteria for the Promotion, Advertisement, and Publicity of Medicines. Washington, DC : PAHO, 2013. (Pan American Network on Drug Regulatory Harmonization - PANDRH Series, Technical Document, 12).
1.Drug Publicity. 2. Products Publicity Control . 3. Ethics.  ISBN 978-92-75-11780-4

This publication aims to support and promote the improvement of health care through the rational use ofmedicines.

PAHO HQ Library Cataloguing-in-Publication Data
Pan American Health Organization, Ministry of Health of Jamaica.
Pharmaceutical Situation in Jamaica. WHO Assessment of Level II - Health Facilities and Household Survey. Washington, D.C.: PAHO, 2012.
(Technical Series: Essential Medicines, Pharmaceutical Policies, Nº 5)
ISBN 978-92-75-11697-5
I. Title. II. Series
1. Pharmaceutical services
2. Pharmacy administration
3. Health facilities
4. Data collection
5. Americas
(NLM Classification: WA730 DJ2)

Pan American Health Organization, Ministry of Health of Saint Lucia.

Pharmaceutical Situation in Saint Lucia. WHO Assessment of Level II - Health Facilities Survey. Washington, D.C.: PAHO, 2012.
ISBN 978-92-75-11696-8
I. Title.
1. Pharmaceutical services
2. Pharmacy administration
3. Health facilities
4. Data collection
5. Americas
(NLM Classification: WA730 DS12)

pdf  Pharmaceutical Situation in Saint Lucia. WHO Assessment of Level II. [2012]. (1.01 MB)

Pan American Health Organization.
Recommendations of the Expert Committee for the Selection and inclusion of Medicines in the
PAHO's Strategic Fund 2015. Washington, DC: PAHO, 2016.
1. Drugs, Essential. 2. Strategic Stockpile - organization & administration. 3. Strategic Planning.
4. Americas. I. Title.
ISBN 978-92-75-11884-9

Report of the Expert Committee for the Selection and Inclusion of Medicines in the Pan American Health Organization Strategic Fund – July 2013. Washington, DC : PAHO, 2013

Strategic Fund; Pharmaceutical Preparations; Chronic Disease; Cardiovascular Diseases; Neoplasms; Immunosuppressive Agents; Complementary Therapies
Americas

Strategic Fund
ISBN 978-92-75-11814-6 (NLM Classification: QV55)

Pan American Health Organization. Technology and Health Services Delivery Area. Essential Medicines, Vaccines and Health Technologies.

Supply of blood for transfusion in the Caribbean and Latin American countries in 2005: Base line data for the Regional Plan of Action for Transfusion Safety 2006-2010. Washington, D.C: PAHO,  2007

Technical Documents. Access to Quality Products (THS/EV/-2007/01 I) ISBN 978 92 75 12852 7

Supply of Blood for Transfusion in the Caribbean and Latin American Countries in 2006-2007: Progress since 2005 of the Regional Plan of Action for Transfusion Safety.

The data presented are related to the pharmaceutical situation of 11 Caribbean countries and two United Kingdom Overseas Territories (UKOTs)- Antigua and Barbuda, Barbados, Dominica, Grenada, Guyana, Jamaica, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Suriname, Trinidad and Tobago, British Virgin Islands and Turks and Caicos Islands- using information collected from 2010 to 2012 within the framework of the Pharmaceutical Sector Country Profiles project. The percentages in the report have been calculated in relation to the total number of respondents for each question. The Caribbean data are compared with that for the Americas region (with a total of 28 participating countries/UKOTs), where possible. Only the information provided by the countries along with an official signed endorsement were included in the individual pharmaceutical country profile and in this publication.